Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 7
1957 11
1958 12
1959 10
1960 9
1961 6
1962 4
1965 11
1966 11
1967 23
1968 14
1969 23
1970 25
1971 15
1972 24
1973 26
1974 38
1975 40
1976 39
1977 44
1978 55
1979 75
1980 89
1981 83
1982 71
1983 84
1984 92
1985 94
1986 79
1987 59
1988 66
1989 71
1990 57
1991 73
1992 56
1993 52
1994 56
1995 53
1996 41
1997 39
1998 34
1999 29
2000 41
2001 23
2002 24
2003 26
2004 31
2005 36
2006 39
2007 40
2008 43
2009 30
2010 21
2011 31
2012 34
2013 20
2014 33
2015 15
2016 30
2017 16
2018 23
2019 17
2020 17
2021 21
2022 21
2023 20
2024 17
2025 21
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,411 results

Results by year

Filters applied: . Clear all
Page 1
Genotype-Guided Hydralazine Therapy.
Collins KS, Raviele ALJ, Elchynski AL, Woodcock AM, Zhao Y, Cooper-DeHoff RM, Eadon MT. Collins KS, et al. Am J Nephrol. 2020;51(10):764-776. doi: 10.1159/000510433. Epub 2020 Sep 14. Am J Nephrol. 2020. PMID: 32927458 Free PMC article. Review.
Hydralazine-Associated Pulmonary-Renal Syndrome.
Mehta SP, Patel NR, Singh J, Kichloo A, Solanki S. Mehta SP, et al. Am J Ther. 2022 Nov-Dec 01;29(6):e667-e669. doi: 10.1097/MJT.0000000000001313. Epub 2021 Feb 2. Am J Ther. 2022. PMID: 33538489 No abstract available.
Hydralazine-induced lupus.
Singh S. Singh S. South Med J. 2006 Jan;99(1):6-7. doi: 10.1097/01.smj.0000197302.13225.08. South Med J. 2006. PMID: 16466108 No abstract available.
A review on the clinical pharmacokinetics of hydralazine.
Shahzad Qamar A, Zamir A, Khalid S, Ashraf W, Imran I, Hussain I, Rehman AU, Saeed H, Majeed A, Alqahtani F, Rasool MF. Shahzad Qamar A, et al. Expert Opin Drug Metab Toxicol. 2022 Oct;18(10):707-714. doi: 10.1080/17425255.2022.2129005. Epub 2022 Sep 27. Expert Opin Drug Metab Toxicol. 2022. PMID: 36150895 Review.
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma.
Shishikura K, Li J, Chen Y, McKnight NR, Keeley TP, Bustin KA, Barr EW, Chilkamari SR, Ayub M, Kim SW, Lin Z, Hu RM, Hicks K, Wang X, O'Rourke DM, Martin Bollinger J Jr, Binder ZA, Parsons WH, Martemyanov KA, Liu A, Matthews ML. Shishikura K, et al. Sci Adv. 2025 Oct 17;11(42):eadx7687. doi: 10.1126/sciadv.adx7687. Epub 2025 Oct 15. Sci Adv. 2025. PMID: 41091880 Free PMC article.
Direct-acting vasodilators.
Cohn JN, McInnes GT, Shepherd AM. Cohn JN, et al. J Clin Hypertens (Greenwich). 2011 Sep;13(9):690-2. doi: 10.1111/j.1751-7176.2011.00507.x. Epub 2011 Jul 18. J Clin Hypertens (Greenwich). 2011. PMID: 21896152 Free PMC article. Review.
Hydralazine-induced cholestatic hepatitis.
Hassan A, Hammad R, Cucco R, Niranjan S. Hassan A, et al. Am J Ther. 2009 Jul-Aug;16(4):371-3. doi: 10.1097/MJT.0b013e31817fde85. Am J Ther. 2009. PMID: 19092641
Perioperative hypertension management.
Varon J, Marik PE. Varon J, et al. Vasc Health Risk Manag. 2008;4(3):615-27. doi: 10.2147/vhrm.s2471. Vasc Health Risk Manag. 2008. PMID: 18827911 Free PMC article. Review.
2,411 results